AstraZeneca Prilosec Patent Litigation Decision By Mid-Year, Andrx Says
Executive Summary
Andrx expects a decision regarding AstraZeneca's Prilosec (omeprazole) patent litigation by mid-year
You may also be interested in...
AstraZeneca Prilosec Patent Trial Hinges On Definition Of “Subcoating”
The outcome of AstraZeneca's Prilosec patent case will likely hinge on the Manhattan federal court's interpretation of the term "subcoating.
AstraZeneca Prilosec Patent Trial Hinges On Definition Of “Subcoating”
The outcome of AstraZeneca's Prilosec patent case will likely hinge on the Manhattan federal court's interpretation of the term "subcoating.
Patent Listing Review Should Be FDA Function, Rep. DeLauro Suggests
FDA should review patents before they are listed in the "Orange Book," members of the House Agriculture Appropriations Subcommittee suggested March 21